Detalhe da pesquisa
1.
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment.
Haematologica;
109(3): 777-786, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37731379
2.
Toxicity of CAR T-Cell Therapy for Multiple Myeloma.
Acta Haematol;
2024 May 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38718775
3.
Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma: U.S. Myeloma Immunotherapy Consortium real world experience.
Haematologica;
2023 10 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37855036
4.
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.
Eur J Haematol;
110(6): 626-632, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36752328
5.
Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences.
Breast J;
2022: 1447545, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36685664
6.
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant;
24(11): 2197-2203, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30016656
7.
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant;
23(4): 581-587, 2017 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28063964
8.
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
Transpl Infect Dis;
19(1)2017 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27862740
9.
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant;
21(8): 1413-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25842049
10.
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant;
20(11): 1767-71, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25017763
11.
Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Ann Surg Oncol;
21(11): 3466-72, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24796968
12.
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience.
Transplant Cell Ther;
30(3): 308.e1-308.e13, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38151105
13.
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel.
J Hematol Oncol;
17(1): 42, 2024 Jun 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38845015
14.
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy.
Blood Adv;
8(1): 251-259, 2024 01 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37855718
15.
Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The U.S. Myeloma Immunotherapy Consortium Real World Experience.
Transplant Cell Ther;
2024 Jun 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38834151
16.
Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy.
Cancers (Basel);
15(11)2023 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37296856
17.
Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab-Naïve Relapsed Multiple Myeloma.
Cancers (Basel);
15(19)2023 Oct 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37835587
18.
Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohort.
Leuk Res;
125: 107001, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36566538
19.
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.
J Clin Oncol;
41(11): 2087-2097, 2023 04 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36623248
20.
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
Transplant Cell Ther;
29(4): 264.e1-264.e9, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35605883